Novel and emerging therapies for B cell lymphoma
Abstract Lymphomas are a heterogeneous group of lymphoproliferative disorders, with unique clinical and biological characteristics that exhibit variable response to therapy. Advances in chemo-immunotherapy have improved outcomes in a number of lymphoma subtypes; however, the prognosis for many patie...
| Những tác giả chính: | , |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | English |
| Được phát hành: |
BMC
2019-07-01
|
| Loạt: | Journal of Hematology & Oncology |
| Những chủ đề: | |
| Truy cập trực tuyến: | http://link.springer.com/article/10.1186/s13045-019-0752-3 |